Immunotherapeutic agents for the management of BCG refractory non-muscle invasive bladder cancer

M. C. Smaldone; J. R. Gingrich

Immunotherapeutic agents for the management of BCG refractory non-muscle invasive bladder cancer

University of Pittsburgh

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	129-132
Number of pages	4
Journal	Minerva Urologica e Nefrologica
Volume	62
Issue number	2
State	Published - Jun 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{1548c8e3be144fd99a5df9b50f17895f,

title = "Immunotherapeutic agents for the management of BCG refractory non-muscle invasive bladder cancer",

author = "Smaldone, {M. C.} and Gingrich, {J. R.}",

year = "2010",

month = jun,

language = "English",

volume = "62",

pages = "129--132",

journal = "Minerva Urologica e Nefrologica",

issn = "0393-2249",

publisher = "Edizioni Minerva Medica S.p.A.",

number = "2",

}

TY - JOUR

T1 - Immunotherapeutic agents for the management of BCG refractory non-muscle invasive bladder cancer

AU - Smaldone, M. C.

AU - Gingrich, J. R.

PY - 2010/6

Y1 - 2010/6

UR - http://www.scopus.com/inward/record.url?scp=77957695665&partnerID=8YFLogxK

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000208661400001&DestLinkType=FullRecord&DestApp=WOS

M3 - Editorial

C2 - 20562792

SN - 0393-2249

VL - 62

SP - 129

EP - 132

JO - Minerva Urologica e Nefrologica

JF - Minerva Urologica e Nefrologica

IS - 2

ER -

Immunotherapeutic agents for the management of BCG refractory non-muscle invasive bladder cancer

UN SDGs

Other files and links

Fingerprint

Cite this